Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling

Journal of Immunology

Volumn 187, Issue 4, 2011, Pages 1529-1535

  Fessler, Michael B ^a   Parks, John S ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; DOCOSAHEXAENOIC ACID; EDELFOSINE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SQUALENE SYNTHASE INHIBITOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

CAVEOLA; CD8+ T LYMPHOCYTE; CELL MEMBRANE; CHOLESTEROL SYNTHESIS; ENDOPLASMIC RETICULUM; INFLAMMATION; INNATE IMMUNITY; LIPID RAFT; LIPID TRANSPORT; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; CAVEOLAE; CHOLESTEROL; HUMANS; INFLAMMATION; MACROPHAGES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 80051937076     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100253     Document Type: Short Survey

References (92)

1. Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature 387: 569-572. (Pubitemid 27248754)
2. Jacobson, K., O. G. Mouritsen, and R. G. Anderson. 2007. Lipid rafts: At a crossroad between cell biology and physics. Nat. Cell Biol. 9: 7-14. (Pubitemid 46024188)
3. Simons, K., and M. J. Gerl. 2010. Revitalizing membrane rafts: New tools and insights. Nat. Rev. Mol. Cell Biol. 11: 688-699.
4. Lingwood, D., and K. Simons. 2010. Lipid rafts as a membrane-organizing principle. Science 327: 46-50.
5. Pike, L. J. 2009. The challenge of lipid rafts. J. Lipid Res. 50(Suppl.): S323-S328.
6. Heerklotz, H. 2002. Triton promotes domain formation in lipid raft mixtures. Biophys. J. 83: 2693-2701. (Pubitemid 35265761)
7. Smart, E. J., Y. Ying, W. C. Donzell, and R. G. Anderson. 1996. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J. Biol. Chem. 271: 29427-29435. (Pubitemid 26382662)
8. Wang, X. M., H. P. Kim, K. Nakahira, S. W. Ryter, and A. M. Choi. 2009. The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J. Immunol. 182: 3809-3818.
9. Gargalovic, P., and L. Dory. 2003. Caveolins and macrophage lipid metabolism. J. Lipid Res. 44: 11-21. (Pubitemid 36114765)
10. Chen, X., and M. D. Resh. 2002. Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor. J. Biol. Chem. 277: 49631-49637. (Pubitemid 36014404)
11. Pike, L. J., and L. Casey. 2002. Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. Biochemistry 41: 10315-10322. (Pubitemid 34856457)
12. Chen, C. L., I. H. Liu, S. J. Fliesler, X. Han, S. S. Huang, and J. S. Huang. 2007. Cholesterol suppresses cellular TGF-β responsiveness: Implications in atherogenesis. J. Cell Sci. 120: 3509-3521. (Pubitemid 350120944)
13. Lee, A. G. 2004. How lipids affect the activities of integral membrane proteins. Biochim. Biophys. Acta 1666: 62-87. (Pubitemid 39425199)
14. Legler, D. F., O. Micheau, M. A. Doucey, J. Tschopp, and C. Bron. 2003. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFa-mediated NF-κB activation. Immunity 18: 655-664. (Pubitemid 36588582)
15. Epand, R. M. 2004. Do proteins facilitate the formation of cholesterol-rich domains? Biochim. Biophys. Acta 1666: 227-238. (Pubitemid 39425206)
16. Min, C. K., S. Y. Bang, B. A. Cho, Y. H. Choi, J. S. Yang, S. H. Lee, S. Y. Seong, K. W. Kim, S. Kim, J. U. Jung, et al. 2008. Role of amphipathic helix of a herpesviral protein in membrane deformation and T cell receptor downregulation. PLoS Pathog. 4: e1000209.
17. Hashimoto-Tane, A., T. Yokosuka, C. Ishihara, M. Sakuma, W. Kobayashi, and T. Saito. 2010. T-cell receptor microclusters critical for T-cell activation are formed independently of lipid raft clustering. Mol. Cell. Biol. 30: 3421-3429.
18. Harder, T., and K. R. Engelhardt. 2004. Membrane domains in lymphocytes: From lipid rafts to protein scaffolds. Traffic 5: 265-275. (Pubitemid 38455750)
19. Ng, G., K. Sharma, S. M. Ward, M. D. Desrosiers, L. A. Stephens, W. M. Schoel, T. Li, C. A. Lowell, C. C. Ling, M. W. Amrein, and Y. Shi. 2008. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity 29: 807-818.
20. Waterfield, J. D., T. A. Ali, F. Nahid, K. Kusano, and D. M. Brunette. 2010. The effect of surface topography on early NFκB signaling in macrophages. J. Biomed. Mater. Res. A 95: 837-847.
21. Lingwood, D., J. Ries, P. Schwille, and K. Simons. 2008. Plasma membranes are poised for activation of raft phase coalescence at physiological temperature. Proc. Natl. Acad. Sci. USA 105: 10005-10010.
22. Hao, M., S. Mukherjee, and F. R. Maxfield. 2001. Cholesterol depletion induces large scale domain segregation in living cell membranes. Proc. Natl. Acad. Sci. USA 98: 13072-13077. (Pubitemid 33051319)
23. Mahammad, S., J. Dinic, J. Adler, and I. Parmryd. 2010. Limited cholesterol depletion causes aggregation of plasma membrane lipid rafts inducing T cell activation. Biochim. Biophys. Acta 1801: 625-634.
24. Solomkin, J. S., C. T. Robinson, C. M. Cave, B. Ehmer, and A. B. Lentsch. 2007. Alterations in membrane cholesterol cause mobilization of lipid rafts from specific granules and prime human neutrophils for enhanced adherence-dependent oxidant production. Shock 28: 334-338. (Pubitemid 47282025)
25. Eisenberg, S., D. E. Shvartsman, M. Ehrlich, and Y. I. Henis. 2006. Clustering of raft-associated proteins in the external membrane leaflet modulates internal leaflet H-ras diffusion and signaling. Mol. Cell. Biol. 26: 7190-7200. (Pubitemid 44477695)
26. Nakahira, K., H. P. Kim, X. H. Geng, A. Nakao, X. Wang, N. Murase, P. F. Drain, X. Wang, M. Sasidhar, E. G. Nabel, et al. 2006. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J. Exp. Med. 203: 2377-2389. (Pubitemid 44498371)
27. Krauss, K., and P. Altevogt. 1999. Integrin leukocyte function-associated antigen-1-mediated cell binding can be activated by clustering of membrane rafts. J. Biol. Chem. 274: 36921-36927.
28. Gekara, N. O., T. Jacobs, T. Chakraborty, and S. Weiss. 2005. The cholesterol-dependent cytolysin listeriolysin O aggregates rafts via oligomerization. Cell. Microbiol. 7: 1345-1356. (Pubitemid 41179426)
29. Park, J. M., V. H. Ng, S. Maeda, R. F. Rest, and M. Karin. 2004. Anthrolysin O and other Gram-positive cytolysins are Toll-like receptor 4 agonists. J. Exp. Med. 200: 1647-1655. (Pubitemid 40094188)
30. Zidovetzki, R., and I. Levitan. 2007. Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategies. Biochim. Biophys. Acta 1768: 1311-1324. (Pubitemid 46782714)
31. Furuchi, T., and R. G. Anderson. 1998. Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J. Biol. Chem. 273:21099-21104. (Pubitemid 28385396)
32. Janes, P. W., S. C. Ley, and A. I. Magee. 1999. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J. Cell Biol. 147: 447-461. (Pubitemid 29496350)
33. Shaikh, S. R., B. D. Rockett, M. Salameh, and K. Carraway. 2009. Docosahexaenoic acid modifies the clustering and size of lipid rafts and the lateral organization and surface expression of MHC class I of EL4 cells. J. Nutr. 139: 1632-1639.
34. Murphy, A. J., K. J. Woollard, A. Hoang, N. Mukhamedova, R. A. Stirzaker, S. P. McCormick, A. T. Remaley, D. Sviridov, and J. Chin-Dusting. 2008. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler. Thromb. Vasc. Biol. 28: 2071-2077.
35. Smythies, L. E., C. R. White, A. Maheshwari, M. N. Palgunachari, G. M. Anantharamaiah, M. Chaddha, A. R. Kurundkar, and G. Datta. 2010. Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages. Am. J. Physiol. Cell Physiol. 298: C1538-C1548.
36. Pommier, A. J., G. Alves, E. Viennois, S. Bernard, Y. Communal, B. Sion, G. Marceau, C. Damon, K. Mouzat, F. Caira, et al. 2010. Liver X receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene 29: 2712-2723.
37. Brusselmans, K., L. Timmermans, T. Van de Sande, P. P. Van Veldhoven, G. Guan, I. Shechter, F. Claessens, G. Verhoeven, and J. V. Swinnen. 2007. Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation. J. Biol. Chem. 282: 18777-18785. (Pubitemid 47100167)
38. Hillyard, D. Z., C. D. Nutt, J. Thomson, K. J. McDonald, R. K. Wan, A. J. Cameron, P. B. Mark, and A. G. Jardine. 2007. Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation. Atherosclerosis 191: 319-325. (Pubitemid 46400716)
39. Blair, A., P.W. Shaul, I. S. Yuhanna, P. A. Conrad, and E. J. Smart. 1999. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J. Biol. Chem. 274: 32512-32519.
40. Walton, K. A., A. L. Cole, M. Yeh, G. Subbanagounder, S. R. Krutzik, R. L. Modlin, R. M. Lucas, J. Nakai, E. J. Smart, D. K. Vora, and J. A. Berliner. 2003. Specific phospholipid oxidation products inhibit ligand activation of Toll-like receptors 4 and 2. Arterioscler. Thromb. Vasc. Biol. 23: 1197-1203. (Pubitemid 36871273)
41. Diaz, O., S. Mébarek-Azzam, A. Benzaria, M. Dubois, M. Lagarde, G. Némoz, and A. F. Prigent. 2005. Disruption of lipid rafts stimulates phospholipase d activity in human lymphocytes: Implication in the regulation of immune function. J. Immunol. 175: 8077-8086. (Pubitemid 41798370)
42. Legler, D. F., M. A. Doucey, J. C. Cerottini, C. Bron, and I. F. Luescher. 2001. Selective inhibition of CTL activation by a dipalmitoyl- phospholipid that prevents the recruitment of signaling molecules to lipid rafts. FASEB J. 15: 1601-1603.
43. Abate, W., A. A. Alghaithy, J. Parton, K. P. Jones, and S. K. Jackson. 2010. Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains. J. Lipid Res. 51: 334-344.
44. Hayashi, T., P. A. Juliet, A. Miyazaki, L. J. Ignarro, and A. Iguchi. 2007. High glucose downregulates the number of caveolae in monocytes through oxidative stress from NADPH oxidase: Implications for atherosclerosis. Biochim. Biophys. Acta 1772: 364-372. (Pubitemid 46275435)
45. Dolganiuc, A., G. Bakis, K. Kodys, P. Mandrekar, and G. Szabo. 2006. Acute ethanol treatment modulates Toll-like receptor-4 association with lipid rafts. Alcohol. Clin. Exp. Res. 30: 76-85. (Pubitemid 43341399)
46. Duan, W., J. Zhou, S. Zhang, K. Zhao, L. Zhao, K. Ogata, T. Sakaue, A. Mori, and T. Wei. 2011. ESeroS-GS modulates lipopolysaccharide-induced macrophage activation by impairing the assembly of TLR-4 complexes in lipid rafts. Biochim. Biophys. Acta 1813: 772-783.
47. Smoak, K. A., J. J. Aloor, J. Madenspacher, B. A. Merrick, J. B. Collins, X. Zhu, G. Cavigiolio, M. N. Oda, J. S. Parks, and M. B. Fessler. 2010. Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation. Cell Metab. 11: 493-502.
48. Fessler, M. B., P. G. Arndt, S. C. Frasch, J. G. Lieber, C. A. Johnson, R. C. Murphy, J. A. Nick, D. L. Bratton, K. C. Malcolm, and G. S. Worthen. 2004. Lipid rafts regulate lipopolysaccharide-induced activation of Cdc42 and inflammatory functions of the human neutrophil. J. Biol. Chem. 279: 39989-39998. (Pubitemid 39258273)
49. Surviladze, Z., L. Dráberová, M. Kovárová, M. Boubelík, and P. Dráber. 2001. Differential sensitivity to acute cholesterol lowering of activation mediated via the high-affinity IgE receptor and Thy-1 glycoprotein. Eur. J. Immunol. 31: 1-10.
50. Lambert, S., D. Vind-Kezunovic, S. Karvinen, and R. Gniadecki. 2006. Ligand-independent activation of the EGFR by lipid raft disruption. J. Invest. Dermatol. 126: 954-962.
51. Gniadecki, R. 2004. Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis. Biochem. Biophys. Res. Commun. 320: 165-169. (Pubitemid 38781797)
52. Matthews, V., B. Schuster, S. Schütze, I. Bussmeyer, A. Ludwig, C. Hundhausen, T. Sadowski, P. Saftig, D. Hartmann, K. J. Kallen, and S. Rose-John. 2003. Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). J. Biol. Chem. 278: 38829-38839. (Pubitemid 37221782)
53. Murai, T., Y. Maruyama, K. Mio, H. Nishiyama, M. Suga, and C. Sato. 2011. Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration. J. Biol. Chem. 286: 1999-2007.
54. Von Tresckow, B., K. J. Kallen, E. P. Von Strandmann, P. Borchmann, H. Lange, A. Engert, and H. P. Hansen. 2004. Depletion of cellular cholesterol and lipid rafts increases shedding of CD30. J. Immunol. 172: 4324-4331. (Pubitemid 38375247)
55. Tellier, E., M. Canault, M. Poggi, B. Bonardo, A. Nicolay, M. C. Alessi, G. Nalbone, and F. Peiretti. 2008. HDLs activate ADAM17-dependent shedding. J. Cell. Physiol. 214: 687-693. (Pubitemid 351224213)
56. Zhu, X., J. Y. Lee, J. M. Timmins, J. M. Brown, E. Boudyguina, A. Mulya, A. K. Gebre, M. C. Willingham, E. M. Hiltbold, N. Mishra, et al. 2008. Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances proinflammatory response of macrophages. J. Biol. Chem. 283: 22930-22941.
57. Zhu, X., J. S. Owen, M. D. Wilson, H. Li, G. L. Griffiths, M. J. Thomas, E. M. Hiltbold, M. B. Fessler, and J. S. Parks. 2010. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J. Lipid Res. 51: 3196-3206.
58. Madenspacher, J. H., D. W. Draper, K. A. Smoak, H. Li, G. L. Griffiths, B. T. Suratt, M. D. Wilson, L. L. Rudel, and M. B. Fessler. 2010. Dyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypes. J. Immunol. 185: 1660-1669.
59. Oiknine, J., and M. Aviram. 1992. Increased susceptibility to activation and increased uptake of low density lipoprotein by cholesterol-loaded macrophages. Arterioscler. Thromb. 12: 745-753.
60. Sun, Y., M. Ishibashi, T. Seimon, M. Lee, S. M. Sharma, K. A. Fitzgerald, A. O. Samokhin, Y. Wang, S. Sayers, M. Aikawa, et al. 2009. Free cholesterol accumulation in macrophage membranes activates Toll-like receptors and p38 mitogen-activated protein kinase and induces cathepsin K. Circ. Res. 104: 455-465.
61. Hamilton, T. A., G. P. Ma, and G. M. Chisolm. 1990. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-a mRNA in stimulated murine peritoneal macrophages. J. Immunol. 144: 2343-2350. (Pubitemid 20106578)
62. Haga, Y., K. Takata, N. Araki, K. Sakamoto, M. Akagi, Y. Morino, and S. Horiuchi. 1989. Intracellular accumulation of cholesteryl esters suppresses production of lipopolysaccharide-induced interleukin 1 by rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 160: 874-880. (Pubitemid 19140603)
63. Ikonen, E. 2008. Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol. Cell Biol. 9: 125-138. (Pubitemid 351158918)
64. Garver, W. S., K. Krishnan, J. R. Gallagos, M. Michikawa, G. A. Francis, and R. A. Heidenreich. 2002. Niemann-Pick C1 protein regulates cholesterol transport to the trans-Golgi network and plasma membrane caveolae. J. Lipid Res. 43: 579-589.
65. Lusa, S., T. S. Blom, E. L. Eskelinen, E. Kuismanen, J. E. Månsson, K. Simons, and E. Ikonen. 2001. Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane. J. Cell Sci. 114: 1893-1900.
66. Landry, Y. D., M. Denis, S. Nandi, S. Bell, A. M. Vaughan, and X. Zha. 2006. ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions. J. Biol. Chem. 281: 36091-36101. (Pubitemid 46041342)
67. Peshavariya, H., G. J. Dusting, B. Di Bartolo, K. A. Rye, P. J. Barter, and F. Jiang. 2009. Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts. Free Radic. Res. 43: 772-782.
68. Fielding, P. E., J. S. Russel, T. A. Spencer, H. Hakamata, K. Nagao, and C. J. Fielding. 2002. Sterol efflux to apolipoprotein A-I originates from caveolin-rich microdomains and potentiates PDGF-dependent protein kinase activity. Biochemistry 41: 4929-4937. (Pubitemid 34298660)
69. Gaus, K., L. Kritharides, G. Schmitz, A. Boettcher, W. Drobnik, T. Langmann, C. M. Quinn, A. Death, R. T. Dean, and W. Jessup. 2004. Apolipoprotein A-1 interaction with plasma membrane lipid rafts controls cholesterol export from macrophages. FASEB J. 18: 574-576.
70. Assanasen, C., C. Mineo, D. Seetharam, I. S. Yuhanna, Y. L. Marcel, M. A. Connelly, D. L. Williams, M. De la Llera-Moya, P. W. Shaul, and D. L. Silver. 2005. Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling. J. Clin. Invest. 115: 969-977. (Pubitemid 40489401)
71. Sviridov, D., N. Fidge, G. Beaumier-Gallon, and C. Fielding. 2001. Apolipoprotein A-I stimulates the transport of intracellular cholesterol to cell-surface cholesterol-rich domains (caveolae). Biochem. J. 358: 79-86. (Pubitemid 32778100)
72. Koseki, M., K. Hirano, D. Masuda, C. Ikegami, M. Tanaka, A. Ota, J. C. Sandoval, Y. Nakagawa-Toyama, S. B. Sato, T. Kobayashi, et al. 2007. Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-a secretion in Abca1-deficient macrophages. J. Lipid Res. 48: 299-306. (Pubitemid 46220596)
73. Francone, O. L., L. Royer, G. Boucher, M. Haghpassand, A. Freeman, D. Brees, and R. J. Aiello. 2005. Increased cholesterol deposition, expression of scavenger receptors, and response to chemotactic factors in Abca1-deficient macrophages. Arterioscler. Thromb. Vasc. Biol. 25: 1198-1205. (Pubitemid 40776609)
74. Yvan-Charvet, L., C. Welch, T. A. Pagler, M. Ranalletta, M. Lamkanfi, S. Han, M. Ishibashi, R. Li, N. Wang, and A. R. Tall. 2008. Increased inflammatory gene expression in ABC transporter-deficient macrophages: Free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 118: 1837-1847.
75. Draper, D. W., J. H. Madenspacher, D. Dixon, D. H. King, A. T. Remaley, and M. B. Fessler. 2010. ATP-binding cassette transporter G1 deficiency dysregulates host defense in the lung. Am. J. Respir. Crit. Care Med. 182: 404-412.
76. Suzuki, M., Y. Sugimoto, Y. Ohsaki, M. Ueno, S. Kato, Y. Kitamura, H. Hosokawa, J. P. Davies, Y. A. Ioannou, M. T. Vanier, et al. 2007. Endosomal accumulation of Toll-like receptor 4 causes constitutive secretion of cytokines and activation of signal transducers and activators of transcription in Niemann-Pick disease type C (NPC) fibroblasts: A potential basis for glial cell activation in the NPC brain. J. Neurosci. 27: 1879-1891.
77. Thompson, P. A., K. C. Gauthier, A. W. Varley, and R. L. Kitchens. 2010. ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance. J. Lipid Res. 51: 2672-2685.
78. Van der Luit, A. H., M. Budde, S. Zerp, W. Caan, J. B. Klarenbeek, M. Verheij, and W. J. Van Blitterswijk. 2007. Resistance to alkyl-lysophospholipid- induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid rafts. Biochem. J. 401: 541-549. (Pubitemid 46166435)
79. Xu, X., R. Bittman, G. Duportail, D. Heissler, C. Vilcheze, and E. London. 2001. Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts): Comparison of cholesterol to plant, fungal, and disease-associated sterols and comparison of sphingomyelin, cerebrosides, and ceramide. J. Biol. Chem. 276: 33540-33546.
80. Megha,, and E. London. 2004. Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function. J. Biol. Chem. 279: 9997-10004.
81. Yu, C., M. Alterman, and R. T. Dobrowsky. 2005. Ceramide displaces cholesterol from lipid rafts and decreases the association of the cholesterol binding protein caveolin-1. J. Lipid Res. 46: 1678-1691. (Pubitemid 41099335)
82. Grassmé, H., V. Jendrossek, A. Riehle, G. Von Kürthy, J. Berger, H. Schwarz, M. Weller, R. Kolesnick, and E. Gulbins. 2003. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat. Med. 9: 322-330. (Pubitemid 36362788)
83. Cuschieri, J., E. Bulger, J. Billgrin, I. Garcia, and R. V. Maier. 2007. Acid sphingomyelinase is required for lipid raft TLR4 complex formation. Surg. Infect. (Larchmt) 8: 91-106.
84. Fischer, H., P. Ellström, K. Ekström, L. Gustafsson, M. Gustafsson, and C. Svanborg. 2007. Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4. Cell. Microbiol. 9: 1239-1251. (Pubitemid 46547141)
85. Jackson, S. K., W. Abate, J. Parton, S. Jones, and J. L. Harwood. 2008. Lysophospholipid metabolism facilitates Toll-like receptor 4 membrane translocation to regulate the inflammatory response. J. Leukoc. Biol. 84: 86-92. (Pubitemid 351960283)
86. Myers, S. J., and K. K. Stanley. 1999. Src family kinase activation in glycosphingolipid-rich membrane domains of endothelial cells treated with oxidised low density lipoprotein. Atherosclerosis 143: 389-397. (Pubitemid 29166921)
87. Walton, K. A., B. G. Gugiu, M. Thomas, R. J. Basseri, D. R. Eliav, R. G. Salomon, and J. A. Berliner. 2006. A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products. J. Lipid Res. 47: 1967-1974. (Pubitemid 44401984)
88. Lu, S. P., M. H. Lin Feng, H. L. Huang, Y. C. Huang, W. I. Tsou, and M. Z. Lai. 2007. Reactive oxygen species promote raft formation in T lymphocytes. Free Radic. Biol. Med. 42: 936-944.
89. Stulnig, T. M., M. Berger, T. Sigmund, D. Raederstorff, H. Stockinger, and W. Waldhäusl. 1998. Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains. J. Cell Biol. 143: 637-644. (Pubitemid 28512560)
90. Wassall, S. R., and W. Stillwell. 2008. Docosahexaenoic acid domains: The ultimate non-raft membrane domain. Chem. Phys. Lipids 153: 57-63.
91. Hitosugi, T., M. Sato, K. Sasaki, and Y. Umezawa. 2007. Lipid raft specific knockdown of SRC family kinase activity inhibits cell adhesion and cell cycle progression of breast cancer cells. Cancer Res. 67: 8139-8148. (Pubitemid 47395149)
92. Mollinedo, F., J. De la Iglesia-Vicente, C. Gajate, A. Estella-Hermoso de Mendoza, J. A. Villa-Pulgarin, M. A. Campanero, and M. J. Blanco-Prieto. 2010. Lipid raft-targeted therapy in multiple myeloma. Oncogene 29: 3748-3757.